Lantus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM
Condition:   To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Intervention:   Drug: Glargine and regular insulin versus NPH and regular insulin Sponsor:   King Edward Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2023 Category: Research Source Type: clinical trials

To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.
Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: INS068 injection;   Drug: Insulin Glargine Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2023 Category: Research Source Type: clinical trials